Export Ready — 

Emerging diabetes therapies: Bringing back the β-cells

Background: Stem cell therapies are finally coming of age as a viable alternative to pancreatic islet transplantation for the treatment of insulin-dependent diabetes. Several clinical trials using human embryonic stem cell (hESC)-derived β-like cells are currently underway, with encouraging prelimin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: G. Basile, M.M.F. Qadir, F. Mauvais-Jarvis, A. Vetere, V. Shoba, A.E. Modell, R.L. Pastori, H.A. Russ, B.K. Wagner, J. Dominguez-Bendala
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2022-06-01
Edice:Molecular Metabolism
Témata:
Islet regeneration
Beta cell proliferation
Pancreatic progenitor cells
Human embryonic stem cell transplantation
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2212877822000461
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky